跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MINT-ZOLPIDEM ODT - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MINT-ZOLPIDEM ODT
Authorized
STANDARD
MINT-ZOLPIDEM ODT
mint pharmaceuticals inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
e62dfeee9128e7d3
Company
mint pharmaceuticals inc
Type
Standard
Approval Details
Approval Id
e62dfeee9128e7d3
Drug Approval Canada Name
MINT-ZOLPIDEM ODT
Product Name
MINT-ZOLPIDEM ODT
Status
Marketed
Status Date
2021-03-19
Original Market Date
2021-03-19
Din
02472821
Drug Class
Human
Dosage Form
Tablet (Orally Disintegrating)
Route Of Administration
Sublingual
Schedule
Targeted (CDSA IV)
Ahfs
28:24.92
Atc Original
N05CF02 ZOLPIDEM
Atc Name
n 05 cf 02
Aig Number
0122857001
Company Name
mint pharmaceuticals inc
Company Address
6575 Davand Drive, Mississauga, Ontario, Canada, L5T 2M3
Active Ingredients
ZOLPIDEM TARTRATE
5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
e62dfeee9128e7d3
Type
Standard
Back to Health Canada Approvals